The FDA was supposed to make a final decision about approval of Novavax's COVID-19 vaccine this week, but that deadline has ...
Amid a period of great upheaval at the agency, the FDA has missed its deadline to decide on approval for Novavax’s COVID-19 ...
The delayed decision comes amid a major organizational shakeup that included the departure of top vaccine official Peter ...
Dr. Peter Marks is being forced to resign from the FDA because the Trump administration does not want someone who is ...
The Food and Drug Administration missed the deadline for making a decision regarding a Covid-19 vaccine from Novavax (NVAX), Liz Essley Whyte ...
The FDA was scheduled to release its decision on Novavax’s updated, protein-based COVID-19 vaccine on April 1.
The US drug regulator has missed a deadline for granting full approval to Novavax's COVID-19 vaccine, the company said ...
The FDA delays full approval for Novavax's COVID-19 vaccine, citing the need for additional data. Read more here.
Novavax's COVID-19 vaccine received FDA Emergency Use Authorization, but full approval faces delays as regulators request more data beyond the April 1 deadline.